Insider Transactions in Q2 2024 at Cullinan Oncology, Inc. (CGEM)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2024
|
Thomas Ebeling |
BUY
Exercise of conversion of derivative security
|
Direct |
18,450
+9.0%
|
$239,850
$13.0 P/Share
|
|
May 23
2024
|
Thomas Ebeling |
BUY
Grant, award, or other acquisition
|
Direct |
100,699
+22.31%
|
$805,592
$8.52 P/Share
|
|
May 07
2024
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,606
-4.15%
|
$168,180
$30.06 P/Share
|
|
May 07
2024
|
Jennifer Michaelson Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,606
+3.98%
|
$22,424
$4.3 P/Share
|
|
May 06
2024
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
58,000
-16.82%
|
$1,624,000
$28.18 P/Share
|
|
May 06
2024
|
Jennifer Michaelson Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+21.05%
|
$200,000
$4.3 P/Share
|